These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 242206)

  • 1. Active enhancement of tissue allografts with antilymphocyte serum and bone marrow.
    Monaco AP; Liegeois A; Wood ML; Clark AW
    Adv Nephrol Necker Hosp; 1975; 5():135-72. PubMed ID: 242206
    [No Abstract]   [Full Text] [Related]  

  • 2. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of antilymphocyte serum and bone marrow for production of immunological tolerance and enhancement: review and recent experiments.
    Wood ML; Gozzo JJ; Monaco AP
    Transplant Proc; 1972 Dec; 4(4):523-9. PubMed ID: 4405146
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of allogenic, homozygous bone marrow cells for the induction of specific immunologic tolerance in mice treated with antilymphocyte serum.
    Gozzo JJ; Wood ML; Monaco AP
    Surg Forum; 1970; 21():281-4. PubMed ID: 4936984
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell-mediated immunity and serum blocking factor in tolerance produced in mice with antilymphocyte serum and bone marrow cell infusion.
    Wood ML; Gozzo JJ; Heppner G; Monaco AP
    Transplant Proc; 1972 Sep; 4(3):383-9. PubMed ID: 4263511
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of augmented graft survival in mice after ALS and bone marrow infusion.
    Wood ML; Heppner G; Gozzo JJ; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):691-6. PubMed ID: 4572128
    [No Abstract]   [Full Text] [Related]  

  • 7. Bone marrow origin of nonsensitized effector cells in skin allograft rejection.
    Kongshavn PA; Lapp WS
    Transplantation; 1973 Oct; 16(4):382-4. PubMed ID: 4583154
    [No Abstract]   [Full Text] [Related]  

  • 8. Survey of the current status of the clinical uses of antilymphocyte serum.
    Monaco AP; Codish SD
    Surg Gynecol Obstet; 1976 Mar; 142(3):417-26. PubMed ID: 766248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of phytohemagglutinin and antilymphocyte globulin in inducing immunosuppression and tolerance in mice.
    Moore CD; Slavin RG
    Transplantation; 1971 Jun; 11(6):563-6. PubMed ID: 4931456
    [No Abstract]   [Full Text] [Related]  

  • 10. Models of specific unresponsiveness to tissue allografts in antilymphocyte serum (ALS) treated mice.
    Wood ML; Monaco AP
    Transplant Proc; 1978 Jun; 10(2):379-87. PubMed ID: 354127
    [No Abstract]   [Full Text] [Related]  

  • 11. Time-dependence of ALS effects on immunological and haematopoietic activities in mice.
    Nouza K; Haskovcová H; Nĕmec M
    Folia Biol (Praha); 1971; 17(5):312-21. PubMed ID: 4399318
    [No Abstract]   [Full Text] [Related]  

  • 12. Immune response to soluble H-2Kd antigens.
    Götze D; Reisfeld RA
    Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(1):45-61. PubMed ID: 4283031
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro modification of donor bone marrow used to produce enhanced graft survival in antilymphocyte serum (ALS)-treated mice.
    Gozzo JJ; Wood ML; Pompei R; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):853-6. PubMed ID: 4572148
    [No Abstract]   [Full Text] [Related]  

  • 14. Possible active enhancement of a human cadaver renal allograft with antilymphocyte serum (ALS) and donor bone marrow: case report of an initial attempt.
    Monaco AP; Clark AW; Wood ML; Sahyoun AI; Codish SD; Brown RW
    Surgery; 1976 Apr; 79(4):384-92. PubMed ID: 769219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vivo activity of in vitro immunized mouse thymocytes. II. Rejection of skin allografts and graft-vs-host activity.
    Rouse BT; Wagner H
    J Immunol; 1972 Dec; 109(6):1282-9. PubMed ID: 4404454
    [No Abstract]   [Full Text] [Related]  

  • 16. The double barrier in bone marrow transplantation.
    van Bekkum DW
    Semin Hematol; 1974 Jul; 11(3):325-40. PubMed ID: 4151846
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolongation of the survival of skin allografts by the injection of spleen cells in adult mice treated by antilymphocyte serum.
    Brochier J; Fries D
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):303-7. PubMed ID: 4559763
    [No Abstract]   [Full Text] [Related]  

  • 18. Sex difference in specific and non-specific suppression of non-H-2 allograft responsiveness in mice.
    Nĕmec M
    Folia Biol (Praha); 1971; 17(4):220-6. PubMed ID: 4943668
    [No Abstract]   [Full Text] [Related]  

  • 19. The suppression of sheep rosette-forming cells and the inability of mouse bone marrow cells to reconstitute competence after infbction with the nematode Trichinella spiralis.
    Faubert GM; Tanner CE
    Immunology; 1974 Sep; 27(3):501-5. PubMed ID: 4607261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on heterologous antilymphocyte serum in mice. VII. Optimal cellular antigen for induction of immunologic tolerance with antilymphocyte serum.
    Monaco AP; Wood ML
    Transplant Proc; 1970 Dec; 2(4):489-96. PubMed ID: 4939696
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.